Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
334,4 GBX | +0,87 % | +2,64 % | +3,96 % |
26.04. | WOCHENVORSCHAU/29. April bis 5. Mai (18. KW) | DJ |
25.04. | Moody's bestätigt die Ratings von Haleon aufgrund der starken operativen Leistung | MT |
Kurzporträt
- Mundgesundheitsprodukte (27,7%; Nr. 1 weltweit): Sensodyne, Parodontax, Polident, Biotene, Aquafresh, usw.;
- Medikamente zur Schmerzlinderung (23,5%; Nr. 1 weltweit): Panadol, Advil, Voltaren, Excedrin, usw.;
- Medikamente für die Verdauung (18,9%; Nr. 1 weltweit): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium, usw.;
- Arzneimittel für die Atemwege (15,4%; Nr. 1 weltweit): Theraflu, Otrivin, Flonase, Contac Marken, etc;
- Vitamine, Mineralstoffe und Nahrungsergänzungsmittel (14,5%; weltweit die Nr. 1): Marken Centrum, Emergen-C, Caltrate, usw.
Der Nettoumsatz verteilt sich geographisch wie folgt: Europa/Mittlerer Osten/Afrika/Lateinamerika (40,2%), Nordamerika (37,1%) und Asien/Pazifik (22,7%).
Mitarbeiterzahl: 25 408
Umsatz nach Geschäftsbereich
GBP in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Oral Health
27,7
%
| 2 957 | 27,2 % | 3 136 | 27,7 % | +6,05 % |
Pain Relief
23,5
%
| 2 551 | 23,5 % | 2 652 | 23,5 % | +3,96 % |
Digestive Health and Other
18,9
%
| 2 096 | 19,3 % | 2 138 | 18,9 % | +2,00 % |
Respiratory Health
15,4
%
| 1 579 | 14,5 % | 1 736 | 15,4 % | +9,94 % |
Vitamins, Minerals and Supplements
14,5
%
| 1 675 | 15,4 % | 1 640 | 14,5 % | -2,09 % |
Umsatz je Region
GBP in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
EMEA and Latin America
40,2
%
| 4 270 | 39,3 % | 4 545 | 40,2 % | +6,44 % |
North America
37,1
%
| 4 116 | 37,9 % | 4 195 | 37,1 % | +1,92 % |
APAC
22,7
%
| 2 472 | 22,8 % | 2 562 | 22,7 % | +3,64 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Brian McNamara
CEO | Chief Executive Officer | 57 | 22.07.21 |
Tobias Hestler
DFI | Director of Finance/CFO | 52 | 01.12.21 |
Franck Riot
CTO | Chief Tech/Sci/R&D Officer | - | 16.12.21 |
Sonya Ghobrial
IRC | Investor Relations Contact | - | - |
Tamara Rogers
SAM | Sales & Marketing | - | 16.12.21 |
Lisa Paley
PRN | Corporate Officer/Principal | - | - |
Keith Choy
PRN | Corporate Officer/Principal | - | - |
Filippo Lanzi
PRN | Corporate Officer/Principal | - | - |
Mairéad Nayager
HRO | Human Resources Officer | - | 01.03.22 |
Bjarne Tellmann
LAW | General Counsel | 57 | 16.12.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bryan Supran
BRD | Director/Board Member | - | 18.07.22 |
Dame Cox
BRD | Director/Board Member | 63 | 18.07.22 |
Tracy Clarke
BRD | Director/Board Member | 57 | 18.07.22 |
Vindi Banga
BRD | Director/Board Member | 69 | 18.07.22 |
Deirdre Mahlan
BRD | Director/Board Member | 61 | 18.07.22 |
David Lewis
CHM | Chairman | 59 | 23.05.22 |
David Denton
BRD | Director/Board Member | 59 | 01.03.23 |
Brian McNamara
CEO | Chief Executive Officer | 57 | 22.07.21 |
Director/Board Member | - | 18.07.22 | |
Asmita Dubey
BRD | Director/Board Member | - | 18.07.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 9 132 301 104 | 7 072 820 336 ( 77,45 %) | 0 | 77,45 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
GlaxoSmithKline Consumer Pvt Ltd.
GlaxoSmithKline Consumer Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Consumer Pvt Ltd. is an Indian company that develops, manufactures, and distributes vaccines and other pharmaceutical products. The private company is based in Patiala, India and was founded in 2014. |
Pharmaceuticals: Major
|
GlaxoSmithKline Consumer Healthcare Finance Ltd.
GlaxoSmithKline Consumer Healthcare Finance Ltd. Financial ConglomeratesFinance Founded in 2014, GlaxoSmithKline Consumer Healthcare Finance Ltd. is a British company that provides investment services. Part of GSK Plc, the private company is based in Brentford, UK. |
Financial Conglomerates
|
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK. |
Financial Conglomerates
|
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd.
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. is a British company that offers Voltarol patches and plasters for effective pain relief. The private company is based in Brentford, UK. The text from the 'description' mentions that Voltarol offers different kinds of patches and plasters for pain relief and provides information on common causes of foot and ankle pain. The company was founded in 2014. |
Financial Conglomerates
|
Haleon UK Trading Services Ltd.
Haleon UK Trading Services Ltd. Drugstore ChainsRetail Trade Part of Haleon Uk Holdings (No. 3) Ltd., Haleon UK Trading Services Ltd. is a wholesaler of pharmaceutical goods. The private company is based in Weybridge, UK. Founded in 2012. |
Drugstore Chains
|
GSK Consumer Healthcare Capital US LLC
GSK Consumer Healthcare Capital US LLC Medical/Nursing ServicesHealth Services Part of Haleon Plc, Haleon US Capital LLC is a private company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE. |
Medical/Nursing Services
|
Haleon UK Capital Plc
Haleon UK Capital Plc Regional BanksFinance Part of Haleon Plc, Haleon UK Capital Plc is a financial intermediation company. Haleon UK Capital Plc is based in Middlesex, UK. The British company was founded in 2021. The CEO is Brian James McNamara. |
Regional Banks
|
Gsk Consumer Healthcare Capital Nl BV
Gsk Consumer Healthcare Capital Nl BV Pharmaceuticals: OtherHealth Technology Part of Haleon Plc, Haleon Netherlands Capital BV is a British company that manufactures medicinal and botanicals. The private company is located in the UK. |
Pharmaceuticals: Other
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+3,96 % | 38,04 Mrd. | |
+25,83 % | 661 Mrd. | |
+27,00 % | 566 Mrd. | |
-6,76 % | 352 Mrd. | |
+20,34 % | 332 Mrd. | |
+3,00 % | 283 Mrd. | |
+13,09 % | 231 Mrd. | |
+5,46 % | 200 Mrd. | |
-9,61 % | 195 Mrd. | |
-6,26 % | 145 Mrd. |
- Börse
- Aktien
- A3DNZQ Aktie
- Unternehmen Haleon plc